PharmaResearch Co., Ltd.: debt-to-equity, ROE and more
KOSDAQ, Legal name PharmaResearch Co., Ltd.
Latest figures are the FY2025 consolidated summary statements.
Latest fiscal year ratios (computed here)
- Debt/equity
- 44.2%
- Equity ratio
- 69.3%
- ROE
- 23.2%
- Op. margin
- 40.0%
- Rev. growth
- 53.2%
- Interest coverage
- n/a
Condition flags
- Operating profit for 5 straight years.
- Total equity is above paid-in capital. Not capital-impaired.
Interest coverage and dividends (OpenDART)
Interest expense and dividends come from DART's OpenDART annual-report filings, not the FSC summary statements used above. The source differs from the other tables on this page.
Interest coverage = operating profit ÷ interest expenseNo interest expense value yet for this company. Most companies fold interest expense into a single finance-costs line on their income statement, so it cannot be pulled out separately. Interest coverage is not computed here.
Dividends, last 3 fiscal years
| Fiscal year | Cash dividend per share | Payout ratio |
|---|---|---|
| 2025 | ₩3,700 | 25.9% |
| 2024 | ₩1,100 | 14.6% |
| 2023 | ₩950 | 12.7% |
Cash dividends for 3 straight years (only the 3 years OpenDART returns).
Source values from the OpenDART (금융감독원 전자공시) annual report. Report fiscal year 2025.
Ratios by year (computed here)
Debt-to-equity = total liabilities ÷ total equity × 100Equity ratio = total equity ÷ total assets × 100ROE = net income ÷ year-end total equity × 100Operating margin = operating profit ÷ revenue × 100Revenue growth = (this year − last year) ÷ last year × 100
Computed from the source figures above with these formulas. Where the source's own debt-to-equity differs from ours, both are shown for that year.
| Fiscal year | Debt/equity | Equity ratio | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| FY2021 consolidated | 30.2% | 76.8% | 14.3% | 34.1% | n/a |
| FY2022 consolidated | 28.6% | 77.7% | 11.7% | 33.8% | 26.4% |
| FY2023 consolidated | 15.8% | 86.3% | 16.7% | 35.3% | 34.0% |
| FY2024 consolidated | 50.3% | 66.5% | 15.6% | 36.0% | 34.1% |
| FY2025 consolidated | 44.2% | 69.3% | 23.2% | 40.0% | 53.2% |
Source figures (FSC summary statements)
Amounts are the source values, shortened. A cell reported as zero may be blank in the source, so it is not used in any ratio.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | ₩154.1B | ₩194.8B | ₩261.0B | ₩350.1B | ₩536.3B |
| Operating profit | ₩52.5B | ₩65.9B | ₩92.3B | ₩126.1B | ₩214.4B |
| Pre-tax income | ₩56.0B | ₩54.0B | ₩100.7B | ₩115.8B | ₩216.5B |
| Net income | ₩46.8B | ₩43.4B | ₩77.3B | ₩88.9B | ₩168.3B |
| Total assets | ₩427.6B | ₩478.1B | ₩535.3B | ₩855.7B | ₩1.04T |
| Total liabilities | ₩99.3B | ₩106.4B | ₩73.1B | ₩286.3B | ₩320.0B |
| Total equity | ₩328.4B | ₩371.7B | ₩462.2B | ₩569.4B | ₩723.9B |
| Paid-in capital | ₩5.1B | ₩5.1B | ₩5.2B | ₩5.3B | ₩5.3B |
| Debt/equity (source value) | 30.2% | 28.6% | 15.8% | 50.3% | 44.2% |
Company outline (FSC)
- Market
- KOSDAQ
- Fiscal year end
- Dec
- Founded
- 2001-03-03
- Listed
- 15/07/24
- Employees
- 526
- Auditor
- 리안회계법인
- Audit opinion
- 적정의견
- Corporate reg. no.
- 1101112183749
- Outline updated
- 2026-09-24
Check the original filings
Read the annual report and audit report before you decide anything. The link opens a DART search for this company's name.
Search DART for 파마리서치Computed from the Financial Services Commission's company outline and summary statements (data.go.kr). Data as of 2026-09-24.